Insight Molecular Diagnostics (IMDX) Treasury Shares (2019 - 2026)

Insight Molecular Diagnostics has reported Treasury Shares for 8 years, with the latest figure at $684000.0 in Q1 2026.

• Quarterly Treasury Shares fell 9.52% year-over-year to $684000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $684000.0 (down 9.52% YoY) and the FY2025 annual result came in at $852000.0, up 752.0% from the prior year.
• Treasury Shares declined to $684000.0 in Q1 2026 per IMDX's latest filing, from $852000.0 in the prior quarter.
• Over five years, Treasury Shares peaked at $1.5 million in Q3 2022 and troughed at $4818.0 in Q4 2023.
• A 5-year average of $470987.9 and a median of $581000.0 in 2022 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2023 and 2025: Treasury Shares sank 99.66% in 2023, then surged 15020.0% in 2025.
• Over 5 years, Treasury Shares stood at $22000.0 in 2022, then slumped by 78.1% to $4818.0 in 2023, then soared by 1975.55% to $100000.0 in 2024, then jumped by 752.0% to $852000.0 in 2025, then retreated by 19.72% to $684000.0 in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $684000.0, $852000.0, and $917000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.